Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
about
Pharmacotherapy for Status EpilepticusLacosamide in status epilepticus: Systematic review of current evidence.Evaluation of anticonvulsant and antinociceptive properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and 3-methylpyrrolidine-2,5-dione.The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experienceMedical management of refractory epilepsy--practical treatment with novel antiepileptic drugs.Practice parameters in management of status epileptics.Cardiovascular adverse effects of phenytoin.Stiripentol for the treatment of super-refractory status epilepticus.Polytherapy as first-line in status epilepticus: should we change our practice? "Time is brain"!Safety of intravenous lacosamide in critically ill children.Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures.
P2860
Q26796689-FA6431C0-AD4C-4A3E-9C8D-6D5C30FD5EB1Q30399934-053EB429-F223-4F27-88C1-6FA67763E129Q36568597-72ECAA76-3595-40B3-B3F1-9871F74928ABQ37722778-D383BB8D-10A4-42F0-9269-691900E393D5Q38176649-26787958-CE3B-4F2F-85F0-78CFE6CE6E36Q38208856-97691591-323C-4C32-8970-C22E5DEF6FF9Q38662067-B9BAD257-DEE5-4462-AB06-003365582C41Q41159617-085B3CC2-6C3B-42B9-8B16-21E01544A3F5Q42106788-D605C86A-21E3-4770-AE28-893C2C555BA9Q47243278-9D8DE3F1-F795-44C5-AA3D-3834D702A62FQ48020465-D8BA65BC-2F7A-4424-8C1A-9AFC46A25744
P2860
Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
@en
Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
@nl
type
label
Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
@en
Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
@nl
prefLabel
Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
@en
Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
@nl
P2093
P2860
P356
P1476
Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
@en
P2093
C Kellinghaus
F Stögbauer
P2860
P304
P356
10.1111/ANE.12174
P407
P577
2013-08-13T00:00:00Z